NCT07146672View on ClinicalTrials.gov

Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Solid Tumor Cancer

Interventions

BIOLOGICAL

Super DC Vaccine

Super DC Cell Injection

Trial Locations (1)

Unknown

RECRUITING

Shanghai Mengchao Tumor Hospital, Shanghai

All Listed Sponsors

lead

Shanghai Cell Therapy Group Co.,Ltd

INDUSTRY

NCT07146672 - Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors | Biotech Hunter | Biotech Hunter